Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Biofrontera stock
Learn how to easily invest in Biofrontera stock.
Biofrontera is a drug manufacturers-specialty & generic business based in the US. Biofrontera shares (BFRI) are listed on the NASDAQ and all prices are listed in US Dollars. Biofrontera employs 69 staff and has a trailing 12-month revenue of around $27.7 million.
How to buy Biofrontera stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – BFRI. It's that simple.
Finder Award
Finder Award
eToro
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Biofrontera stock price (NASDAQ: BFRI)
Use our graph to track the performance of BFRI stocks over time.Biofrontera shares at a glance
Information last updated 2023-01-28.
| Latest market close | $0.86 |
|---|---|
| 52-week range | $0.75 - $6.12 |
| 50-day moving average | $0.95 |
| 200-day moving average | $1.66 |
| Wall St. target price | $20.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.59 |
Buy Biofrontera stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Biofrontera stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biofrontera price performance over time
Historical closes compared with the close of $0.861 from 2023-02-01
| 1 week (2023-01-26) | -6.88% |
|---|---|
| 1 month (2022-12-30) | -6.11% |
| 3 months (2022-11-02) | -18.00% |
| 6 months (2022-08-02) | -39.37% |
| 1 year (2022-02-02) | -78.37% |
|---|---|
| 2 years (2021-01-29) | N/A |
| 3 years (2020-01-29) | N/A |
| 5 years (2018-01-29) | N/A |
Biofrontera financials
| Revenue TTM | $27.7 million |
|---|---|
| Gross profit TTM | $11.4 million |
| Return on assets TTM | -18.98% |
| Return on equity TTM | -474.02% |
| Profit margin | -44.62% |
| Book value | $0.96 |
| Market capitalisation | $24.5 million |
TTM: trailing 12 months
Biofrontera share dividends
We're not expecting Biofrontera to pay a dividend over the next 12 months.
Biofrontera overview
Biofrontera Inc. , a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts. .
Frequently asked questions
What percentage of Biofrontera is owned by insiders or institutions?Currently 42.392% of Biofrontera shares are held by insiders and 7.621% by institutions. How many people work for Biofrontera?
Latest data suggests 69 work at Biofrontera. When does the fiscal year end for Biofrontera?
Biofrontera's fiscal year ends in December. Where is Biofrontera based?
Biofrontera's address is: 120 Presidential Way, Woburn, MA, United States, 01801 What is Biofrontera's ISIN number?
Biofrontera's international securities identification number is: US09077D1000
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert